Table 1.
Demographic and clinical characteristics of patients with liver cirrhosis diagnosed with invasive pulmonary aspergillosis (n = 19)
| Characteristic | Patients (n= 19)(%) |
|---|---|
| Sex (males/females) |
12/7 |
| Age, years, median (range) |
54 (30–75) |
| Underlying liver disease |
|
| Hepatitis B virus |
11 (57.89) |
| Alcoholic |
3 (15.79) |
| Autoimmune hepatitis |
1 (5.26) |
| Hybrid cause |
4 (21.05) |
| Basic underlying disease |
|
| Cardiovascular disease |
4 (21.05) |
| Diabetes mellitus type 2 |
2 (10.53) |
| Chronic lung diseases |
2 (10.53) |
| Complications |
|
| Hepatic encephalopathy |
8 (42.10) |
| Hepatic renal syndrome |
4 (21.05) |
| Upper gastric bleeding |
4 (21.05) |
| Ascites |
16 (84.21) |
| Hydrothorax |
10 (52.63) |
| Hepatic carcinoma |
2 (10.53) |
| CTP scores (mean ± SD) |
11 ± 2 |
| Child B |
6 (31.58) |
| Child C |
13 (68.42) |
| MELD (mean ± SD) |
22 ± 7 |
| Neutropenia |
2 (10.53) |
| Broad-spectrum antibiotics usage |
18 (94.74) |
| One antibiotic |
9 (47.37) |
| Two antibiotics |
4 (21.05) |
| Three antibiotics |
5 (26.32) |
| Steroids exposure(longer than 1 week) |
11 (57.89) |
| Survival rate |
|
| 1 month |
5/19 |
| 3 month | 4/19 |
Data presented as n patients or mean ± SD unless stated otherwise.
CTP, Child-Turcotte-Pugh; MELD, Model for End-Stage Liver Disease.